159 related articles for article (PubMed ID: 12638333)
1. [Evaluation of myocardial viability using magnetic resonance imaging--case report].
Pasowicz M; Klimeczek P; Kolasa-Trela R; Wicher-Muniak E; Banyś P; Podolec P; Zmudka K; Tracz W
Przegl Lek; 2002; 59(8):620-2. PubMed ID: 12638333
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance evaluation of myocardial viability and ischemia.
Strzelczyk J; Attili A
Semin Roentgenol; 2008 Jul; 43(3):193-203. PubMed ID: 18486681
[No Abstract] [Full Text] [Related]
3. [Contrast-enhanced MR and MSCT for the assessment of myocardial viability].
Mahnken AH; Günther RW; Krombach G
Rofo; 2006 Aug; 178(8):771-80. PubMed ID: 16862503
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
5. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
Muellerleile K; Barmeyer A; Groth M; Lund GK
Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for myocardial viability.
Siebelink HM; Lamb HJ
EuroIntervention; 2010 May; 6 Suppl G():G107-14. PubMed ID: 20542816
[TBL] [Abstract][Full Text] [Related]
7. Characterization of reversible myocardial dysfunction by magnetic resonance imaging.
Fedele F; Scopinaro F; Montesano T; Di Cesare E; Di Renzi P; Vitarelli A; Dagianti A
Herz; 1994 Aug; 19(4):210-20. PubMed ID: 7959535
[TBL] [Abstract][Full Text] [Related]
8. Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy.
Kaandorp TA; Bax JJ; Schuijf JD; Viergever EP; van Der Wall EE; de Roos A; Lamb HJ
Am J Cardiol; 2004 Jun; 93(12):1461-4. PubMed ID: 15194013
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
Kwong RY; Korlakunta H
Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging first-pass myocardial perfusion in evaluation of hemodynamic effects of myocardial bridging.
Canyigit M; Turkbey B; Hazirolan T; Peynircioglu B; Aytemir K
J Comput Assist Tomogr; 2008; 32(2):274-5. PubMed ID: 18379316
[TBL] [Abstract][Full Text] [Related]
11. Assessment of myocardial viability: review of the clinical significance.
Ramos M; DePasquale E; Coplan NL
Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
[TBL] [Abstract][Full Text] [Related]
12. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging.
Nelson C; McCrohon J; Khafagi F; Rose S; Leano R; Marwick TH
J Am Coll Cardiol; 2004 Apr; 43(7):1248-56. PubMed ID: 15063438
[TBL] [Abstract][Full Text] [Related]
13. Free-breathing high-spatial-resolution delayed contrast-enhanced three-dimensional viability MR imaging of the myocardium at 3.0 T: a feasibility study.
Amano Y; Matsumura Y; Kumita S
J Magn Reson Imaging; 2008 Dec; 28(6):1361-7. PubMed ID: 19025943
[TBL] [Abstract][Full Text] [Related]
14. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment.
Selvanayagam JB; Jerosch-Herold M; Porto I; Sheridan D; Cheng AS; Petersen SE; Searle N; Channon KM; Banning AP; Neubauer S
Circulation; 2005 Nov; 112(21):3289-96. PubMed ID: 16286587
[TBL] [Abstract][Full Text] [Related]
15. Coronary artery disease: combined stress MR imaging protocol-one-stop evaluation of myocardial perfusion and function.
Sensky PR; Jivan A; Hudson NM; Keal RP; Morgan B; Tranter JL; de Bono D; Samani NJ; Cherryman GR
Radiology; 2000 May; 215(2):608-14. PubMed ID: 10796946
[TBL] [Abstract][Full Text] [Related]
16. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
17. Multidetector computed tomography in reperfused acute myocardial infarction. Assessment of infarct size and no-reflow in comparison with cardiac magnetic resonance imaging.
Jacquier A; Boussel L; Amabile N; Bartoli JM; Douek P; Moulin G; Paganelli F; Saeed M; Revel D; Croisille P
Invest Radiol; 2008 Nov; 43(11):773-81. PubMed ID: 18923256
[TBL] [Abstract][Full Text] [Related]
18. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
19. Assessment of myocardial viability by cardiovascular magnetic resonance.
Lloyd SG; Gupta H
Echocardiography; 2005 Feb; 22(2):179-93. PubMed ID: 15693786
[TBL] [Abstract][Full Text] [Related]
20. First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.
Su MY; Yang KC; Wu CC; Wu YW; Yu HY; Tseng RY; Tseng WY
J Cardiovasc Magn Reson; 2007; 9(4):633-44. PubMed ID: 17578718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
